Hubert C. Chen - Feb 25, 2023 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
President and Chief Scientific Officer
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Stock symbol
FBRX
Transactions as of
Feb 25, 2023
Transactions value $
$0
Form type
4
Date filed
2/27/2023, 07:15 PM
Previous filing
Jun 8, 2022
Next filing
Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FBRX Restricted Stock Units Award $0 +120K $0.00 120K Feb 25, 2023 Common Stock 120K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock.
F2 Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, "Quarterly Vesting Date" with respect to any calendar year means January 1, April 1, July 1, and October 1.

Remarks:

President and Chief Scientific Officer